Related Experiment Video
Updated: May 13, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Continuous Subcutaneous Ketamine Infusion May Induce Tacrolimus and Sirolimus Clearance: A Case Report
Jana Stojanova1,2, Bridin Murnion1,2, Fay Burrows3
1Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, Australia.
Continuous ketamine infusions may decrease immunosuppressant levels in transplant patients. This case highlights the need for increased drug monitoring during and after ketamine use to maintain therapeutic drug concentrations.
Area of Science:
- Pharmacology
- Transplant Medicine
- Drug Metabolism
Background:
- Drug interactions with immunosuppressants can impact transplant success.
- Ketamine is increasingly used for pain management via continuous infusion.
- Limited clinical data exists on ketamine's effect on cytochrome P450 (CYP) substrate clearance.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Therapeutic Drug Monitoring: Affecting Factors
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

